Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Split-Dose R-CHOP for Older Adults With DLBCL

NCT03943901

Conditions: Cancer, DLBCL, Diffuse Large B Cell Lymphoma, +11 more
Locations: University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Active, Not Recruiting

Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

NCT04745559

Conditions: Diffuse Large-Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +14 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

NCT01959698

Conditions: CD20 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Active, Not Recruiting

Prognostic Model of Elderly Hodgkin Lymphoma in China

NCT07374068

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, Not Recruiting

Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

NCT04262843

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT03842696

Conditions: Acute Leukemia in Remission, Blast Crisis, Bone Marrow Diseases, +37 more
Locations: University of Colorado Aurora, Colorado, United States

Emory University Atlanta, Georgia, United States

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

University of Michigan Health System Ann Arbor, Michigan, United States

View Trial Details

Active, Not Recruiting

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

NCT05071209

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +23 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

UCSF Medical Center-Mission Bay San Francisco, California, United States

View all 29 locations

View Trial Details

Active, Not Recruiting

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

NCT03642626

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Active, Not Recruiting

Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction

NCT06114498

Conditions: Body Weight, Decompensated Heart Failure, Heart Failure With Preserved Ejection Fraction, +18 more
Locations: Moscow State Clinical Hospital named after V.V. Veresaev Moscow, Russia

National Medical Research Center for Therapy and Preventive Medicine Moscow, Russia

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions